The effect on lymphocyte subsets of decreasing/stopping tyrosine kinase inhibitor therapy in chronic myeloid leukaemia: data from the DESTINY trial



Austin, Gemma M, Knight, Katy, Bell, Joanne, Carter, Anthony, Heartin, Earnest, Watson, David, Foroni, Letizia, Christmas, Stephen E, Polydoros, Fotios and Clark, Richard E ORCID: 0000-0002-1261-3299
(2019) The effect on lymphocyte subsets of decreasing/stopping tyrosine kinase inhibitor therapy in chronic myeloid leukaemia: data from the DESTINY trial. BRITISH JOURNAL OF HAEMATOLOGY, 185 (4). 791 - 793.

[img] Text
paper177 ImmunoDESTINY letter to BJH Aug 9th.docx - Accepted Version

Download (51kB)
Item Type: Article
Uncontrolled Keywords: chronic myeloid leukaemia, treatment discontinuation, lymphocyte subsets, tyrosine kinase inhibitors, imatinib
Depositing User: Symplectic Admin
Date Deposited: 19 Nov 2018 10:39
Last Modified: 09 Jan 2021 04:36
DOI: 10.1111/bjh.15629
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3028927